Literature DB >> 31106524

Challenges to Studying Illicit Drug Users.

Jennie E Ryan1, Suzanne C Smeltzer2, Nancy C Sharts-Hopko3.   

Abstract

PURPOSE: Throughout the world, illicit drug use continues to pose a significant risk to public health. The opioid crisis in North America, the diversion of the prescription drug tramadol throughout Africa, and the increasing supply of methamphetamines in East and South Asia all contribute to increasing risks to individual and societal health. Furthermore, the violation of human rights in efforts to enforce prohibitionist values poses significant threats to many individuals worldwide. With these evolving situations, it is imperative that researchers direct their attention to the various populations of illicit drug users. However, the inclusion of illicit drug users, often considered a vulnerable population, as participants in research studies presents several increased risks that must be addressed in study protocols. Researchers are required to provide "additional safeguards" to all study protocols involving illicit drug users, but there is often substantial variability and inconsistency in how these safeguards are applied. Additional safeguards can be timely, costly, and unduly burdensome for researchers, ethical review boards, and research participants. APPROACH: Through synthesis of the current literature, this article addresses the barriers to studying illicit drug users and the methods researchers can utilize to minimize risk. A case study is provided to illustrate the high level of scrutiny of study protocols involving the participation of illicit drug users and the effect of such scrutiny on recruitment of participants. The article concludes with a discussion of the effects of the current political climate on the recruitment of illicit drug users in research.
CONCLUSIONS: Individuals who participate in criminal or illegal behaviors such as illicit drug use, prostitution, illegal entry into a country, and human trafficking are susceptible to multiple physical, mental, and social health risks, as well as criminal prosecution. The importance of research on the health of marginalized populations cannot be overstated. This work must continue, and at the same time, we must continue to protect these individuals to the best of our ability through diligent attention to sound research methods. CLINICAL RELEVANCE: The use of illicit drugs continues to pose a substantial threat to global health. Individuals who use illicit drugs are susceptible to multiple physical, mental, and social health risks, as well as criminal prosecution. It is imperative that researchers study these vulnerable populations in order to develop interventions to minimize individual and societal harm. There are several barriers to the study of illicit drug users that must be addressed through rigorous methodology and the addition of safeguards.
© 2019 Sigma Theta Tau International.

Entities:  

Keywords:  Illicit drug use; research ethics; research methodology; vulnerable populations

Mesh:

Substances:

Year:  2019        PMID: 31106524      PMCID: PMC6671678          DOI: 10.1111/jnu.12486

Source DB:  PubMed          Journal:  J Nurs Scholarsh        ISSN: 1527-6546            Impact factor:   3.176


  27 in total

1.  Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand.

Authors:  K M MacQueen; S Vanichseni; D Kitayaporn; L S Lin; A Buavirat; T Naiwatanakul; S Raktham; P Mock; W L Heyward; D C Des Jarlais; K Choopanya; T D Mastro
Journal:  J Acquir Immune Defic Syndr       Date:  1999-07-01       Impact factor: 3.731

2.  Distrust, race, and research.

Authors:  Giselle Corbie-Smith; Stephen B Thomas; Diane Marie M St George
Journal:  Arch Intern Med       Date:  2002-11-25

3.  Ethical issues in informed consent with substance abusers.

Authors:  B S McCrady; D A Bux
Journal:  J Consult Clin Psychol       Date:  1999-04

4.  The effects of local review on informed consent documents from a multicenter clinical trials consortium.

Authors:  William Burman; Peter Breese; Stephen Weis; Naomi Bock; John Bernardo; Andrew Vernon
Journal:  Control Clin Trials       Date:  2003-06

5.  "It's like Tuskegee in reverse": a case study of ethical tensions in institutional review board review of community-based participatory research.

Authors:  Ruth E Malone; Valerie B Yerger; Carol McGruder; Erika Froelicher
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

Review 6.  The need for evidence-based research ethics: a review of the substance abuse literature.

Authors:  Emily E Anderson; James M DuBois
Journal:  Drug Alcohol Depend       Date:  2006-08-22       Impact factor: 4.492

7.  Factors affecting African-American participation in AIDS research.

Authors:  S Sengupta; R P Strauss; R DeVellis; S C Quinn; B DeVellis; W B Ware
Journal:  J Acquir Immune Defic Syndr       Date:  2000-07-01       Impact factor: 3.731

8.  Issues presented by mandatory reporting requirements to researchers of child abuse and neglect.

Authors:  Joan E Sieber
Journal:  Ethics Behav       Date:  1994

9.  Variation in standards of research compensation and child assent practices: a comparison of 69 institutional review board-approved informed permission and assent forms for 3 multicenter pediatric clinical trials.

Authors:  Michael B Kimberly; K Sarah Hoehn; Chris Feudtner; Robert M Nelson; Mark Schreiner
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

10.  Research note: ethics of drug treatment research with court-supervised subjects.

Authors:  Gordon DuVal; Christina Salmon
Journal:  J Drug Issues       Date:  2004
View more
  2 in total

1.  Peer recovery services for persons returning from prison: Pilot randomized clinical trial investigation of SUPPORT.

Authors:  Bradley Ray; Dennis P Watson; Huiping Xu; Michelle P Salyers; Grant Victor; Emily Sightes; Katie Bailey; Lisa Robison Taylor; Na Bo
Journal:  J Subst Abuse Treat       Date:  2021-02-27

2.  How ethics committees and requirements are structuring health research in the Philippines: a qualitative study.

Authors:  Gideon Lasco; Vincen Gregory Yu; Lia Palileo-Villanueva
Journal:  BMC Med Ethics       Date:  2021-07-01       Impact factor: 2.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.